OpenLegislation

The Infected Blood Compensation Scheme Regulations 2024 (revoked)

S.I. 2024/872 · Made 22 August 2024 · Extends to United Kingdom

Up to date with all changes known to legislation.gov.uk, revised to 31 March 2025.

Regulations made by the Minister for the Cabinet Office, laid before Parliament under section 79(6) and (7) of the Victims and Prisoners Act 2024, for approval by resolution of each House of Parliament within twenty-eight days beginning with the day on which the Regulations were made, subject to extension for periods of dissolution, prorogation or adjournment for more than four days.

Payment Scheme

Made 22nd August 2024

Laid before Parliament at 10.00 a.m. on 23rd August 2024

Coming into force at 11.00 p.m. on 23rd August 2024

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations to the whole text

Textual amendments

F1

Regulations revoked (31.3.2025) by The Infected Blood Compensation Scheme Regulations 2025 (S.I. 2025/404), regs. 1(2), 86(1) (with savings in reg. 86(2) and transitional provisions in reg. 87)

Contents

  1. Part 1: General Repealed
  2. 1Citation, commencement and extent Repealed
  3. 2Interpretation Repealed
  4. Part 2: Establishment and administration of the infected blood compensation scheme Repealed
  5. 3Establishment of the Scheme Repealed
  6. 4Eligibility criteria for appointment as a member of the IBCA Repealed
  7. 5Cessation of disqualification from eligibility for appointment to the IBCA Repealed
  8. 6Duties of the IBCA in relation to sums repaid to it Repealed
  9. Part 3: Meaning of “eligible infected person” Repealed
  10. 7Meaning of “eligible infected person” Repealed
  11. Part 4: Compensation payments – core route Repealed
  12. Chapter 1: Preliminary Repealed
  13. 8Compensation payments Repealed
  14. 9Person to whom a compensation payment is to be paid Repealed
  15. 10Compensation payments – offer and acceptance Repealed
  16. Chapter 2: Determining the amount of a compensation payment Repealed
  17. 11Amount of a compensation payment Repealed
  18. 12Court and other payments: avoidance of double recovery Repealed
  19. 13Amount of periodic payments Repealed
  20. 14Injury impact award Repealed
  21. 15Social impact award Repealed
  22. 16Autonomy award Repealed
  23. 17Basic financial loss award: eligible infected persons Repealed
  24. 18Additional financial loss award Repealed
  25. 19Additional financial loss award: eligible infected persons with Hepatitis B or Hepatitis C Repealed
  26. 20Additional financial loss award: eligible infected persons with HIV Repealed
  27. 21Care award Repealed
  28. Part 5: Compensation payments – IBSS route Repealed
  29. 22Compensation payments under the IBSS route Repealed
  30. 23Amount of compensation payment under the IBSS route Repealed
  31. 24Interpretation of regulations 25 to 27 Repealed
  32. 25Past financial loss award Repealed
  33. 26Past care award Repealed
  34. 27Support scheme top-up award Repealed
  35. 28Future financial loss and future care awards where an IBSS-registered person dies Repealed
  36. Part 6: Applications for compensation payments from the Scheme Repealed
  37. 29Giving of notices and documents Repealed
  38. 30Applications Repealed
  39. 31Date of application Repealed
  40. 32Time limit for making an application Repealed
  41. 33Applications for those registered under an infected blood support scheme Repealed
  42. 34Amendment or withdrawal of application by the applicant Repealed
  43. 35Duty of applicants Repealed
  44. 36Death before an application has been finally determined Repealed
  45. 37Evidence Repealed
  46. 38Burden of proof and standard of proof Repealed
  47. 39Decisions Repealed
  48. Part 7: Reviews and appeals Repealed
  49. 40Review initiated by the applicant Repealed
  50. 41Review initiated by the IBCA Repealed
  51. 42Appeals Repealed
  52. Part 8: Recovery of overpayments Repealed
  53. 43Recovery of overpayments Repealed
  54. Signature
  55. Schedule Infection severity levels for Hepatitis B and Hepatitis C Repealed
  56. Explanatory note

1Citation, commencement and extentF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2InterpretationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3Establishment of the SchemeF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4Eligibility criteria for appointment as a member of the IBCAF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5Cessation of disqualification from eligibility for appointment to the IBCAF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6Duties of the IBCA in relation to sums repaid to itF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7Meaning of “eligible infected person”F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8Compensation paymentsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9Person to whom a compensation payment is to be paidF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10Compensation payments – offer and acceptanceF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11Amount of a compensation paymentF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12Court and other payments: avoidance of double recoveryF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

13Amount of periodic paymentsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

14Injury impact awardF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

15Social impact awardF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

16Autonomy awardF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

17Basic financial loss award: eligible infected personsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

18Additional financial loss awardF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

19Additional financial loss award: eligible infected persons with Hepatitis B or Hepatitis CF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

20Additional financial loss award: eligible infected persons with HIVF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

21Care awardF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

22Compensation payments under the IBSS routeF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

23Amount of compensation payment under the IBSS routeF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

24Interpretation of regulations 25 to 27F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

25Past financial loss awardF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

26Past care awardF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

27Support scheme top-up awardF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

28Future financial loss and future care awards where an IBSS-registered person diesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

29Giving of notices and documentsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

30ApplicationsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

31Date of applicationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

32Time limit for making an applicationF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

33Applications for those registered under an infected blood support schemeF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

34Amendment or withdrawal of application by the applicantF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

35Duty of applicantsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

36Death before an application has been finally determinedF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

37EvidenceF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

38Burden of proof and standard of proofF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

39DecisionsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

40Review initiated by the applicantF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

41Review initiated by the IBCAF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

42AppealsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

43Recovery of overpaymentsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Infection severity levels for Hepatitis B and Hepatitis CF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Explanatory note

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .